National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 263895

History of Changes from the VAERS Wayback Machine

First Appeared on 12/30/2006

VAERS ID: 263895
Age:18.0
Gender:Female
Location:Maine
Vaccinated:2006-09-25
Onset:2006-09-25
Submitted:2006-09-29
Entered:2006-10-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE, QUADRIVALENT (GARDASIL) / MERCK & CO. INC. 0688F / - LA / IM

Administered by: Other      Purchased by: Unknown
Symptoms: Dyspnoea, Nasopharyngitis, Swelling face, Injection site swelling

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Wellbutrin XL; lithium carbonate; Risperdal
Current Illness:
Preexisting Conditions: Asthma; Polycystic ovaries; cold
Diagnostic Lab Data:
CDC 'Split Type':

Write-up:Information has been received from a registered nurse concerning an 18 year old female with asthma, polycystic ovaries and no known allergies or adverse drug reactions reported. On 25-SEP-2006, the patient was vaccinated intramuscularly with a 0.5 ml dos"e of HPV rLi 6 11 16 18 VLP vaccine (yeast) (lot#653735/0688F). Concomitant therapy included bupropion HCL (WELLBUTRIN XL), lithium carbonate and risperidone (RISPERDAL). That evening, on 25-SEP-2006, the patient developed left arm swelling and difficul


Changed on 12/8/2009

VAERS ID: 263895 Before After
Age:18.0
Gender:Female
Location:Maine
Vaccinated:2006-09-25
Onset:2006-09-25
Submitted:2006-09-29
Entered:2006-10-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE, QUADRIVALENT (GARDASIL) HPV (GARDASIL) / MERCK & CO. INC. 0688F / - LA / IM

Administered by: Other      Purchased by: Unknown Other
Symptoms: Dyspnoea, Nasopharyngitis, Swelling face, Injection site swelling

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Wellbutrin XL; lithium carbonate; Risperdal
Current Illness:
Preexisting Conditions: Asthma; Polycystic ovaries; cold
Diagnostic Lab Data:
CDC 'Split Type': (blank) WAES0609USA06568

Write-up:Information has been received from a registered nurse concerning an 18 year old female with asthma, polycystic ovaries and no known allergies or adverse drug reactions reported. On 25-SEP-2006, the patient was vaccinated intramuscularly with a 0.5 ml dos"e dose of HPV rLi 6 11 16 18 VLP vaccine (yeast) (lot#653735/0688F). Concomitant therapy included bupropion HCL (WELLBUTRIN XL), lithium carbonate and risperidone (RISPERDAL). That evening, on 25-SEP-2006, the patient developed left arm swelling and difficul difficulty breathing. It was reported that the difficulty breathing could be due to the patient having a cold and being an asthmatic. On 26-SEP-2006 the patient developed facial swelling. The patient sought unspecified medical attention. It was reported that a nurse practitioner and physician were doing an assessment and consultation. At the time of this report, the patient was recovering from th events. The reporter considered the events to be serious as other important medical events. Additional information has been requested. (OMIC)


Changed on 1/5/2010

VAERS ID: 263895 Before After
Age:18.0
Gender:Female
Location:Maine
Vaccinated:2006-09-25
Onset:2006-09-25
Submitted:2006-09-29
Entered:2006-10-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Nasopharyngitis, Swelling face, Injection site swelling

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Wellbutrin XL; lithium carbonate; Risperdal
Current Illness: Asthma; Polycystic ovaries; Cold
Preexisting Conditions: Asthma; Polycystic ovaries; cold
Diagnostic Lab Data: None
CDC 'Split Type': WAES0609USA06568

Write-up:Information Initial and follow up information has been received from a registered nurse concerning an 18 year old female with asthma, polycystic ovaries and no known allergies or adverse drug reactions reported. On 25-SEP-2006, the patient was vaccinated intramuscularly with a 0.5 ml dose of HPV rLi 6 11 16 18 VLP vaccine (yeast) (lot#653735/0688F). Concomitant therapy included bupropion HCL (WELLBUTRIN XL), lithium carbonate and risperidone (RISPERDAL). That evening, on 25-SEP-2006, the patient developed left arm swelling and difficulty breathing. It was reported that the difficulty breathing could be due to the patient having a cold and being an asthmatic. On 26-SEP-2006 the patient developed facial swelling. The patient sought unspecified medical attention. It was reported that a nurse practitioner and physician were doing an assessment and consultation. On an unspecified date, the patient had the assessment and consultation and her symptoms were not considered to be serious. At the time of this report, the patient was recovering from th events. The reporter considered the events to be serious as other important medical events. events (date unknown). Additional information has been requested. (OMIC) is not expected.


Changed on 7/31/2010

VAERS ID: 263895 Before After
Age:18.0
Gender:Female
Location:Maine
Vaccinated:2006-09-25
Onset:2006-09-25
Submitted:2006-09-29
Entered:2006-10-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Oedema peripheral, Swelling face

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Wellbutrin XL; lithium carbonate; Risperdal
Current Illness: Asthma; Polycystic ovaries; Cold
Preexisting Conditions: Asthma; Polycystic ovaries; cold
Diagnostic Lab Data: None
CDC 'Split Type': WAES0609USA06568

Write-up:Initial and follow up information has been received from a registered nurse concerning an 18 year old female with asthma, polycystic ovaries and no known allergies or adverse drug reactions reported. On 25-SEP-2006, the patient was vaccinated intramuscularly with a 0.5 ml dose of HPV rLi 6 11 16 18 VLP vaccine (yeast) (lot#653735/0688F). Concomitant therapy included bupropion HCL (WELLBUTRIN XL), lithium carbonate and risperidone (RISPERDAL). That evening, on 25-SEP-2006, the patient developed left arm swelling and difficulty breathing. It was reported that the difficulty breathing could be due to the patient having a cold and being an asthmatic. On 26-SEP-2006 the patient developed facial swelling. The patient sought unspecified medical attention. It was reported that a nurse practitioner and physician were doing an assessment and consultation. On an unspecified date, the patient had the assessment and consultation and her symptoms were not considered to be serious. At the time of this report, the patient was recovering from th events. The reporter considered the events to be serious as other important medical events (date unknown). Additional information is not expected.


Changed on 6/14/2014

VAERS ID: 263895 Before After
Age:18.0
Gender:Female
Location:Maine
Vaccinated:2006-09-25
Onset:2006-09-25
Submitted:2006-09-29
Entered:2006-10-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Oedema peripheral, Swelling face

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Wellbutrin XL; lithium carbonate; Risperdal
Current Illness: Asthma; Polycystic ovaries; Cold
Preexisting Conditions: Asthma; Polycystic ovaries; cold
Diagnostic Lab Data: None
CDC 'Split Type': WAES0609USA06568

Write-up:Initial and follow up information has been received from a registered nurse concerning an 18 year old female with asthma, polycystic ovaries and no known allergies or adverse drug reactions reported. On 25-SEP-2006, the patient was vaccinated intramuscularly with a 0.5 ml dose of HPV rLi 6 11 16 18 VLP vaccine (yeast) (lot#653735/0688F). Concomitant therapy included bupropion HCL (WELLBUTRIN XL), lithium carbonate and risperidone (RISPERDAL). That evening, on 25-SEP-2006, the patient developed left arm swelling and difficulty breathing. It was reported that the difficulty breathing could be due to the patient having a cold and being an asthmatic. On 26-SEP-2006 the patient developed facial swelling. The patient sought unspecified medical attention. It was reported that a nurse practitioner and physician were doing an assessment and consultation. On an unspecified date, the patient had the assessment and consultation and her symptoms were not considered to be serious. At the time of this report, the patient was recovering from th events. The reporter considered the events to be serious as other important medical events (date unknown). Additional information is not expected.


Changed on 2/14/2017

VAERS ID: 263895 Before After
Age:18.0
Gender:Female
Location:Maine
Vaccinated:2006-09-25
Onset:2006-09-25
Submitted:2006-09-29
Entered:2006-10-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / - LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Oedema peripheral, Swelling face

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Wellbutrin XL; lithium carbonate; Risperdal
Current Illness: Asthma; Polycystic ovaries; Cold
Preexisting Conditions: Asthma; Polycystic ovaries; cold
Diagnostic Lab Data: None
CDC 'Split Type': WAES0609USA06568

Write-up:Initial and follow up information has been received from a registered nurse concerning an 18 year old female with asthma, polycystic ovaries and no known allergies or adverse drug reactions reported. On 25-SEP-2006, the patient was vaccinated intramuscularly with a 0.5 ml dose of HPV rLi 6 11 16 18 VLP vaccine (yeast) (lot#653735/0688F). Concomitant therapy included bupropion HCL (WELLBUTRIN XL), lithium carbonate and risperidone (RISPERDAL). That evening, on 25-SEP-2006, the patient developed left arm swelling and difficulty breathing. It was reported that the difficulty breathing could be due to the patient having a cold and being an asthmatic. On 26-SEP-2006 the patient developed facial swelling. The patient sought unspecified medical attention. It was reported that a nurse practitioner and physician were doing an assessment and consultation. On an unspecified date, the patient had the assessment and consultation and her symptoms were not considered to be serious. At the time of this report, the patient was recovering from th events. The reporter considered the events to be serious as other important medical events (date unknown). Additional information is not expected.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=263895&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166